| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | scavenger receptor activity | 4.77e-04 | 27 | 24 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | polysaccharide binding | 6.30e-04 | 31 | 24 | 2 | GO:0030247 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.62e-03 | 739 | 24 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 2.05e-03 | 56 | 24 | 2 | GO:0030170 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 2.12e-03 | 57 | 24 | 2 | GO:0070279 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.65e-03 | 85 | 24 | 2 | GO:0038024 | |
| MousePheno | calcified joint | 2.91e-05 | 7 | 17 | 2 | MP:0003200 | |
| Domain | Tesmin/TSO1-like_CXC | 3.72e-08 | 6 | 24 | 3 | IPR033467 | |
| Domain | CXC | 3.72e-08 | 6 | 24 | 3 | SM01114 | |
| Domain | Somatomedin_B_chordata | 1.58e-05 | 5 | 24 | 2 | IPR020436 | |
| Domain | Laminin_G_2 | 1.79e-05 | 40 | 24 | 3 | PF02210 | |
| Domain | LamG | 2.39e-05 | 44 | 24 | 3 | SM00282 | |
| Domain | Somatomedin_B | 4.41e-05 | 8 | 24 | 2 | PF01033 | |
| Domain | Laminin_G | 5.49e-05 | 58 | 24 | 3 | IPR001791 | |
| Domain | SO | 5.67e-05 | 9 | 24 | 2 | SM00201 | |
| Domain | Somatomedin_B_dom | 7.08e-05 | 10 | 24 | 2 | IPR001212 | |
| Domain | SMB_1 | 7.08e-05 | 10 | 24 | 2 | PS00524 | |
| Domain | SMB_2 | 7.08e-05 | 10 | 24 | 2 | PS50958 | |
| Domain | - | 2.39e-04 | 95 | 24 | 3 | 2.60.120.200 | |
| Domain | VWC | 5.86e-04 | 28 | 24 | 2 | PF00093 | |
| Domain | - | 9.18e-04 | 35 | 24 | 2 | 3.90.1150.10 | |
| Domain | VWFC_1 | 9.71e-04 | 36 | 24 | 2 | PS01208 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 9.71e-04 | 36 | 24 | 2 | IPR015422 | |
| Domain | Growth_fac_rcpt_ | 1.02e-03 | 156 | 24 | 3 | IPR009030 | |
| Domain | LAM_G_DOMAIN | 1.08e-03 | 38 | 24 | 2 | PS50025 | |
| Domain | VWC | 1.08e-03 | 38 | 24 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.08e-03 | 38 | 24 | 2 | PS50184 | |
| Domain | - | 1.14e-03 | 39 | 24 | 2 | 3.40.640.10 | |
| Domain | PyrdxlP-dep_Trfase | 1.26e-03 | 41 | 24 | 2 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 1.26e-03 | 41 | 24 | 2 | IPR015421 | |
| Domain | VWF_dom | 1.32e-03 | 42 | 24 | 2 | IPR001007 | |
| Domain | ConA-like_dom | 2.68e-03 | 219 | 24 | 3 | IPR013320 | |
| Domain | EGF | 3.27e-03 | 235 | 24 | 3 | SM00181 | |
| Domain | EGF-like_dom | 3.85e-03 | 249 | 24 | 3 | IPR000742 | |
| Domain | EGF_1 | 4.12e-03 | 255 | 24 | 3 | PS00022 | |
| Domain | EGF-like_CS | 4.39e-03 | 261 | 24 | 3 | IPR013032 | |
| Domain | EGF_2 | 4.59e-03 | 265 | 24 | 3 | PS01186 | |
| Domain | EGF_Ca-bd_CS | 6.84e-03 | 97 | 24 | 2 | IPR018097 | |
| Domain | EGF_CA | 7.12e-03 | 99 | 24 | 2 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.25e-03 | 100 | 24 | 2 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.12e-03 | 106 | 24 | 2 | IPR000152 | |
| Domain | EGF_CA | 1.06e-02 | 122 | 24 | 2 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.10e-02 | 124 | 24 | 2 | IPR001881 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 1.63e-04 | 16 | 17 | 2 | MM14541 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 1.63e-04 | 16 | 17 | 2 | M514 | |
| Pathway | REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC | 2.84e-04 | 21 | 17 | 2 | M27875 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 3.66e-04 | 119 | 17 | 3 | MM14901 | |
| Pathway | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | 4.37e-04 | 26 | 17 | 2 | M907 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 5.45e-04 | 29 | 17 | 2 | M27528 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 5.45e-04 | 29 | 17 | 2 | MM15253 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 6.24e-04 | 31 | 17 | 2 | MM14705 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 6.24e-04 | 31 | 17 | 2 | M27529 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 6.24e-04 | 31 | 17 | 2 | MM15254 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 6.24e-04 | 31 | 17 | 2 | M16597 | |
| Pathway | KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM | 6.65e-04 | 32 | 17 | 2 | M17758 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING | 7.07e-04 | 33 | 17 | 2 | M27526 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 7.07e-04 | 33 | 17 | 2 | MM15252 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 7.51e-04 | 34 | 17 | 2 | M27527 | |
| Pathway | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | 7.96e-04 | 35 | 17 | 2 | M918 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 8.89e-04 | 37 | 17 | 2 | MM14899 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 9.88e-04 | 39 | 17 | 2 | MM15257 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 1.04e-03 | 40 | 17 | 2 | M27532 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 1.04e-03 | 40 | 17 | 2 | MM15258 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 1.09e-03 | 41 | 17 | 2 | M27533 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 1.37e-03 | 46 | 17 | 2 | MM15949 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 1.56e-03 | 49 | 17 | 2 | MM14695 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 1.58e-03 | 197 | 17 | 3 | M27188 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 1.62e-03 | 50 | 17 | 2 | MM15255 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 30809307 | ||
| Pubmed | TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer. | 1.37e-06 | 3 | 24 | 2 | 24804542 | |
| Pubmed | TET-Mediated Sequestration of miR-26 Drives EZH2 Expression and Gastric Carcinogenesis. | 4.56e-06 | 5 | 24 | 2 | 28923852 | |
| Pubmed | 1.27e-05 | 8 | 24 | 2 | 11856874 | ||
| Pubmed | TET1 regulates fibroblast growth factor 8 transcription in gonadotropin releasing hormone neurons. | 1.64e-05 | 9 | 24 | 2 | 31361780 | |
| Pubmed | Sex-specific chromatin remodelling safeguards transcription in germ cells. | 5.44e-05 | 16 | 24 | 2 | 34880491 | |
| Pubmed | 5.44e-05 | 16 | 24 | 2 | 17767158 | ||
| Pubmed | 1.36e-04 | 25 | 24 | 2 | 19876004 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.37e-04 | 146 | 24 | 3 | 23892456 | |
| Pubmed | 1.96e-04 | 30 | 24 | 2 | 29137925 | ||
| Pubmed | Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. | 5.48e-04 | 50 | 24 | 2 | 24191021 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.05e-02 | 718 | 12 | 3 | 28 | |
| GeneFamily | Ring finger proteins | 1.38e-02 | 275 | 12 | 2 | 58 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_(gd)|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.47e-06 | 180 | 24 | 4 | 44c37644973c4fc555dc966f8cfe1f4f81fef300 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-immature_natural_killer_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.44e-05 | 146 | 24 | 3 | 40fac8a298152ec7f7eeeed5a2d28541aea3b338 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.41e-05 | 153 | 24 | 3 | d3fb83ca984c7583b1e51c364be6c7c17f67b048 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 7.70e-05 | 155 | 24 | 3 | 85eb60d285b8bfc095c341ae90c0e3b7e7dca9c1 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.99e-05 | 157 | 24 | 3 | eea53cf8d8a607264e1ee00b7a97c94bcf2ac80d | |
| ToppCell | ICU-SEP-Myeloid-cDC1|ICU-SEP / Disease, Lineage and Cell Type | 8.61e-05 | 161 | 24 | 3 | 9fb73909fc2ec99f96ca2eed1a053bce89de7d16 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.10e-05 | 164 | 24 | 3 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 9.77e-05 | 168 | 24 | 3 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | Healthy_donor-CD8+_T_naive|Healthy_donor / disease group, cell group and cell class (v2) | 9.94e-05 | 169 | 24 | 3 | 66216758e581365f10c2a66714d83a606ad23af0 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.05e-04 | 172 | 24 | 3 | 1215f61f115b042f84721b64c2ed1f48081535f1 | |
| ToppCell | 3'-Airway_Nasal-Endothelial-Blood_vessel_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 173 | 24 | 3 | b7d8702409b86fbc8741a472b84d509ba261a852 | |
| ToppCell | 3'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 173 | 24 | 3 | b83c9e274999c9325908616cee4a89d425c8c4ed | |
| ToppCell | 3'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 173 | 24 | 3 | 0068c059ef118b5ef85c5b01ad8680ce11493aa5 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 1.07e-04 | 173 | 24 | 3 | 62e0c18cfed9645e34a9d7029c94a8554f773714 | |
| ToppCell | 3'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 173 | 24 | 3 | 3c96e269ca7b7029f533268f68ca4466edd20edd | |
| ToppCell | 3'-Airway_Nasal-Endothelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 173 | 24 | 3 | 383edcd3bb14d3934506260dbbac7167282546af | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD8-Tnaive/CM_CD8|Liver / Manually curated celltypes from each tissue | 1.08e-04 | 174 | 24 | 3 | 03918ca51ae3b4c9c1a74769b08ea23f518286ba | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 175 | 24 | 3 | 955f10982a487e12cdc3a9f80b3be06bf6c59de7 | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(232)_CD4+/CD45RA+_Naive_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 1.10e-04 | 175 | 24 | 3 | fc40fda0fb9954cb0970c6ac71f6d6df7d27dc5c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-04 | 176 | 24 | 3 | 322259a35f5c97d73ce7f75835dcdb5c954c91f8 | |
| ToppCell | PBMC-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters | 1.14e-04 | 177 | 24 | 3 | 974305e4c0eff90134c4e58cf11b955d1eee0501 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 177 | 24 | 3 | c20df760b25caa772278397b02fc36521927cbfc | |
| ToppCell | ICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, Lineage and Cell Type | 1.14e-04 | 177 | 24 | 3 | 33cd2c183ee8b597012efcbcae72131ac6beaf4e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-04 | 178 | 24 | 3 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.22e-04 | 181 | 24 | 3 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 182 | 24 | 3 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-04 | 183 | 24 | 3 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-04 | 183 | 24 | 3 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 184 | 24 | 3 | 1158a55c1990fd23d270cb6510d0951c4bfcddc5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 184 | 24 | 3 | c4c1a3d279ca733b865ce46570d7642dc137f9a4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 184 | 24 | 3 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.30e-04 | 185 | 24 | 3 | 492529121cb9e88bd3c0db6b54af3cd2979572bc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-04 | 185 | 24 | 3 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | Mild-Lymphoid-T-NK|Mild / Condition, Lineage, Cell class and cell subclass | 1.32e-04 | 186 | 24 | 3 | ed37a2df547661d22c1ed0b30cb1c19e489d9d0a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 186 | 24 | 3 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 187 | 24 | 3 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 187 | 24 | 3 | 01393f6d1983eb4a2bcc80252012f77892851679 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_T_(gd)|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.34e-04 | 187 | 24 | 3 | e5713a7bda53d1d5178ab4e0dbadc2292b6005bc | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.36e-04 | 188 | 24 | 3 | 9655a4c47b644a870017d349b99063e17dbae572 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 188 | 24 | 3 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 188 | 24 | 3 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 189 | 24 | 3 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | da2fcd4a2cc6e45c8174109d892f1424e39919a1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 190 | 24 | 3 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 190 | 24 | 3 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | e584eaccbc22aa7f7a4340ed8a2a8b45ddca93f4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 190 | 24 | 3 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 190 | 24 | 3 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.41e-04 | 190 | 24 | 3 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | facs-GAT-Fat-24m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | 3395b2ff6ffadf84cdb1b5a37a5b6be05b56c30f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 190 | 24 | 3 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | 9aaa48f3aad813c87a45efdbb67d255c94f6e6a4 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | 34e56c5e7ea6a8f227dbaefe73cbb8818d18b523 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | 14cdb660ad3aabcf49572173e7628d8b99dcbe6f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 190 | 24 | 3 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.41e-04 | 190 | 24 | 3 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 190 | 24 | 3 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.43e-04 | 191 | 24 | 3 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.43e-04 | 191 | 24 | 3 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-04 | 191 | 24 | 3 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 192 | 24 | 3 | eafead22bba48ac5ee568faa8946c444445c1034 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.45e-04 | 192 | 24 | 3 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-04 | 192 | 24 | 3 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-04 | 193 | 24 | 3 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.47e-04 | 193 | 24 | 3 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-04 | 193 | 24 | 3 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-04 | 193 | 24 | 3 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | CV-Mild|CV / Virus stimulation, Condition and Cluster | 1.49e-04 | 194 | 24 | 3 | 0ce0376c12d8a2ca617f96dd1b7874393238d5a9 | |
| ToppCell | CV-Moderate-5|CV / Virus stimulation, Condition and Cluster | 1.52e-04 | 195 | 24 | 3 | 7a0bb304c659dd108b75d0c5d19eca5e63cf856d | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.52e-04 | 195 | 24 | 3 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.54e-04 | 196 | 24 | 3 | 14dd6956ef420b660be0baf52a66960e57d75d16 | |
| ToppCell | ASK454-Endothelial-Endothelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.54e-04 | 196 | 24 | 3 | 2b777a2026b56839112fd179f2db482c49f4594a | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 197 | 24 | 3 | 87eda06344498dc66cac292cf89746dc90b5cf67 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 1.56e-04 | 197 | 24 | 3 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-cDC1|ICU-SEP / Disease, condition lineage and cell class | 1.56e-04 | 197 | 24 | 3 | e3174e90ea6136f1aa3a4a185b86458e35d51fd4 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 197 | 24 | 3 | e8e879b7634a29569061d3515d180784094a31e7 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.59e-04 | 198 | 24 | 3 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 1.59e-04 | 198 | 24 | 3 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-04 | 198 | 24 | 3 | 8d6b0b9da7c1e64155cbcbb04ad38d129a29030c | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 198 | 24 | 3 | 88b4662be9cc933a402c52673fa5e00fa979c0db | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 198 | 24 | 3 | fa5c15a656d4132950092919600e270f1fd79abf | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.59e-04 | 198 | 24 | 3 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_Tcm|Influenza_Severe / Disease, condition lineage and cell class | 1.59e-04 | 198 | 24 | 3 | fc99f2e300d76126d05c0c43e11cdbbeb74f6f0d | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-04 | 198 | 24 | 3 | d1f54ed3ef5e05ebda7da999e172d168dc6802cd | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-04 | 199 | 24 | 3 | 07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-04 | 199 | 24 | 3 | 6fb81388c5045e81c3849a7136bdff3f953f044e | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-04 | 199 | 24 | 3 | 258d59cf811bf1668ffbb5f18f961021f660de62 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 200 | 24 | 3 | cd3c638961144a2fc91c437a173cc37c7452fa74 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-MEPE-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | d4161fcbbe47236aac4a077c0994887e765b0b47 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | 7534005613ee22aee2bac51070929957dece3c8b | |
| ToppCell | normal_Lung-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.63e-04 | 200 | 24 | 3 | 413ac64bbe95b8c921c5396d8b5f298fec8c4f82 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 200 | 24 | 3 | cee07d9370656e1c428a7a9e9fbd175129901374 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Interneuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | a313b9a8bde1ea80a6eae183b76fba46b86558b4 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 200 | 24 | 3 | 074b5766c61fa8e61d0b1b76688ea0d1ec401e5b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| Disease | congestive heart failure (is_implicated_in) | 2.02e-04 | 27 | 23 | 2 | DOID:6000 (is_implicated_in) | |
| Disease | blood phosphate measurement | 3.27e-04 | 174 | 23 | 3 | EFO_0010972 | |
| Disease | HbA1c measurement | 1.70e-03 | 675 | 23 | 4 | EFO_0004541 | |
| Disease | 3-hydroxy-1-methylpropylmercapturic acid measurement | 2.50e-03 | 352 | 23 | 3 | EFO_0007015 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KCSCAPDCCQAKDQY | 251 | Q9BYV1 | |
| LGCFYPCPKCNSNKC | 106 | P0DKL9 | |
| AACACDQKPCSCSKV | 71 | Q05329 | |
| NNATCKKCEKDYPCS | 381 | Q5T1H1 | |
| YVDGKCCKECKSICQ | 321 | Q99435 | |
| DCLAQCGKDCKSYCC | 26 | Q96J86 | |
| RCKAQCNTKQCPCYL | 561 | Q15910 | |
| CSDDCKDKGDCCINY | 166 | P22413 | |
| CYCKENVQGPKCDQC | 1596 | O15230 | |
| PFQCNICGCKCKNKY | 391 | Q9H5V7 | |
| CPCYSNRKACLDCIC | 481 | Q9HCI7 | |
| KNGSSAKPSCPYCCC | 286 | P54198 | |
| DRPFKCDCCDYSCKN | 281 | Q9BQA5 | |
| CDAEACSCANKYCQT | 571 | O00237 | |
| CSSICKCIGCKNYEE | 391 | Q9Y4I5 | |
| CFLKQYPQCCDCKET | 106 | Q8WXD0 | |
| CDAQCKKYDKCCPDY | 86 | Q92954 | |
| YRCEDCGKCKCKECT | 176 | O43597 | |
| PCQQKTNCGECTYCK | 596 | Q8NFU7 | |
| QCCPQCKERKNYCEF | 206 | Q2TAL6 | |
| PYQCKQCGKAFSCSC | 251 | Q8N8Z8 | |
| CNKPCCDSGDAIYYC | 996 | Q86YV5 | |
| CGKCCLTYCFNKPED | 141 | P62979 | |
| CGDCKFNVCKSCCSY | 81 | Q8NFW9 |